These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34175819)

  • 1. Inhibition of endothelin A receptor by a novel, selective receptor antagonist enhances morphine-induced analgesia: Possible functional interaction of dimerized endothelin A and μ-opioid receptors.
    Kuroda Y; Nonaka M; Kamikubo Y; Ogawa H; Murayama T; Kurebayashi N; Sakairi H; Miyano K; Komatsu A; Dodo T; Nakano-Ito K; Yamaguchi K; Sakurai T; Iseki M; Hayashida M; Uezono Y
    Biomed Pharmacother; 2021 Sep; 141():111800. PubMed ID: 34175819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development.
    Gulati A; Bhalla S; Matwyshyn G
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S129-31. PubMed ID: 15838261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro evaluation of novel μ-opioid receptor agonist compounds.
    Nikaido Y; Kurosawa A; Saikawa H; Kuroiwa S; Suzuki C; Kuwabara N; Hoshino H; Obata H; Saito S; Saito T; Osada H; Kobayashi I; Sezutsu H; Takeda S
    Eur J Pharmacol; 2015 Nov; 767():193-200. PubMed ID: 26476280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
    Kaski SW; White AN; Gross JD; Trexler KR; Wix K; Harland AA; Prisinzano TE; Aubé J; Kinsey SG; Kenakin T; Siderovski DP; Setola V
    J Pharmacol Exp Ther; 2019 Nov; 371(2):487-499. PubMed ID: 31492823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
    Andurkar SV; Gendler L; Gulati A
    Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
    Lu Z; Xu J; Xu M; Rossi GC; Majumdar S; Pasternak GW; Pan YX
    Anesth Analg; 2018 Mar; 126(3):1050-1057. PubMed ID: 28991118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.
    Chen W; Ennes HS; McRoberts JA; Marvizón JC
    Neuropharmacology; 2018 Jan; 128():255-268. PubMed ID: 29042318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
    Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
    Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin ETA receptor blockade potentiates morphine analgesia but does not affect gastrointestinal transit in mice.
    Matwyshyn GA; Bhalla S; Gulati A
    Eur J Pharmacol; 2006 Aug; 543(1-3):48-53. PubMed ID: 16814278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
    Schiene K; Schröder W; Linz K; Frosch S; Tzschentke TM; Jansen U; Christoph T
    Eur J Pharmacol; 2018 Aug; 832():90-95. PubMed ID: 29753041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
    Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
    Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noribogaine is a G-protein biased κ-opioid receptor agonist.
    Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
    Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.
    Grenald SA; Young MA; Wang Y; Ossipov MH; Ibrahim MM; Largent-Milnes TM; Vanderah TW
    Neuropharmacology; 2017 Apr; 116():59-70. PubMed ID: 28007501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.